Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Pediatr Adolesc Gynecol ; 32(6): 574-578, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31445141

ABSTRACT

STUDY OBJECTIVE: To evaluate genital microbiological findings in prepubertal girls with vulvovaginitis and in healthy controls. DESIGN: Prospective case-control study. SETTING: Pediatric Outpatient unit of the Department of Pediatrics of the Hospital of the Lithuanian University of Health Sciences Kauno Klinikos from November 2014 to May 2017. PARTICIPANTS: Fifty-two prepubertal girls aged 1-9 years diagnosed with vulvovaginitis, and 42 age-matched healthy controls. INTERVENTIONS AND MAIN OUTCOME MEASURES: Samples for microbiological culture were collected using sterile cotton swabs from the introitus and the lower third of the vagina from all study participants. Microbiological findings were analyzed according to bacteria type and intensity of growth. RESULTS: Most of the vaginal microbiological swab results were positive for bacterial growth: 47 (90.4%) and 34 (80.9%) were similar in the study and control groups, respectively (P = .24). Sixteen (30.8%) and 9 (21.4%) of the microbiological traits results in the case and control groups, respectively, were regarded as potential causative agents (P = .27). Streptococcus pyogenes was the most frequent pathogen in the study group (P = .03); all other microorganisms detected as either a pure or dominant growth in the control group, were considered opportunistic. CONCLUSIONS: Vaginal bacterial culture results were positive in prepubertal girls with vulvovaginitis and in healthy controls. Nonspecific vulvovaginitis without a dominant/isolated pathogen was seen to be more common than vulvovaginitis with a potential causative agent. Clinical symptoms were more frequent among girls when the potential infectious agent was identified.


Subject(s)
Streptococcus pyogenes/growth & development , Vulvovaginitis/microbiology , Case-Control Studies , Child , Child, Preschool , Female , Humans , Infant , Prospective Studies , Vagina/microbiology
2.
APMIS ; 121(5): 431-6, 2013 May.
Article in English | MEDLINE | ID: mdl-23078193

ABSTRACT

The study evaluated the changes in the prevalence of Helicobacter pylori strains with primary resistance to antibiotics during the last 10 years in Lithuania. H. pylori susceptibilities to antibiotics were tested in 89 patients in 1998, in 81 patients in 2001 and in 90 patients in 2007/2008. Susceptibility to metronidazole, clarithromycin, amoxicillin and tetracycline was tested using E-test or agar dilution method. Susceptibility to ciprofloxacin was only tested in 2007/2008. Data about utilization of all authorized and available on market macrolides and clindamycin in Lithuania during 2003-2007 were evaluated using WHO ATC/DDD methodology. A total of 260 H. pylori strains cultured from untreated adult patients were investigated. Primary resistance rates (1998, 2001 and 2007/2008) for metronidazole were 24.7%, 33.3%, and 35.6%, for clarithromycin 1.1%, 3.7%, and 3.3% and for tetracycline 0%, 2.5% and 0% respectively. No cases of amoxicillin resistance have been detected. The resistance rate for ciprofloxacin was 5.6% in 2007/2008. Data of total macrolides and clarithromycin utilization in Lithuania revealed that despite an increase of consumption of these drugs in Lithuania during 2003-2007 in 1.5 times, the total macrolide consumption remains one of the lowest in Europe. We have not observed any significant changes in the susceptibility of H. pylori to the most widely used antibiotics during the recent 10-year period. The low resistance rate to clarithromycin might be related to the policy to avoid use of macrolides as first-line treatment for pulmonary and other infections.


Subject(s)
Drug Resistance, Multiple, Bacterial , Helicobacter Infections/epidemiology , Helicobacter pylori/drug effects , Adult , Amoxicillin/pharmacology , Anti-Bacterial Agents/pharmacology , Ciprofloxacin/pharmacology , Clarithromycin/pharmacology , Clindamycin/pharmacology , Evolution, Molecular , Female , Helicobacter Infections/drug therapy , Helicobacter pylori/pathogenicity , Humans , Lithuania/epidemiology , Male , Metronidazole/pharmacology , Microbial Sensitivity Tests , Middle Aged , Prevalence , Tetracycline/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...